[Preliminary report on the effects of immunosuppressive therapy with azathioprine in glomerulonephritis].
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use*; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008466:Mechlorethamine / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D008875:Middle Aged
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D008466:Mechlorethamine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001379:Azathioprine
Primi reperti intorno agli effetti della terapia immunosoppressiva con azatioprina nella glomerulonefrite.